Purpose | This immunoassay kit allows for the specific measurement of Human interferon-inducible protein 10 (IP-10/CXCL10) concentrations in cell culture supernates, Saliva ,serum, and plasma. |
Sample Type | Cell Culture Supernatant, Serum, Plasma |
Analytical Method | Quantitative |
Detection Method | Colorimetric |
Specificity | This assay recognizes natural Human IP-10. |
Cross-Reactivity (Details) | No significant cross-reactivity or interference was observed. |
Sensitivity |
< 19 pg/mL The sensitivity of this assay, or Lower Limit of Detection (LLD) was defined as the lowest detectable concentration that could be differentiated from zero. |
Characteristics | Homo sapiens,Human,C-X-C motif chemokine 10,10 kDa interferon gamma-induced protein,Gamma-IP10,IP-10,Small-inducible cytokine B10,CXCL10,INP10,SCYB10 |
Components | Reagent (Quantity): Assay plate (1), Standard (2), Sample Diluent (1x20ml), Assay Diluent A (1x10ml), Assay Diluent B (1x10ml), Detection Reagent A (1x120μl), Detection Reagent B (1x120μl), Wash Buffer(25 x concentrate) (1x30ml), Substrate (1x10ml), Stop Solution (1x10ml) |
Alternative Name | CXCL10 (CXCL10 ELISA Kit Abstract) |
Background | IP-10 (interferon-gamma inducible protein 10 kDa), also known as CXCL10, was originally identified as an IFN--inducible gene. It is induced in a variety of cells in response to IFN-and LPS. In contrast to other CXC chemokines, IP-10 has no chemotactic activity for neutrophils. It is a pleiotropic molecule that appears to target activated T cells and monocytes. IP-10 inhibits bone marrow colony formation and angiogenesis .It can also stimulate NK andT cell migration, regulate T cell maturation and modulate adhesion molecule expression. IP-10 cDNA encodes a 98 amino acid (aa) precursor protein with a 21 aa signal peptide that is cleaved to generate a 77 aa mature protein .The aa sequence of IP-10 indicates that it is a member of a subfamily of CXC chemokines lacking the ELR domain.CXCR3 is a receptor for both IP-10 and MIG .It is highly expressed in IL-2-activated T lymphocytes and can also be expressed on eosinophils ,yet is undetectable in resting T lymphocytes, B lymphocytes, monocytes or granulocytes. CXCR3 can also be expressed on CD34+ hematopoietic progenitors from human cord blood stimulated with GM-CSF, but not on freshly isolated CD34+ progenitor cells .CXCR3 promotes Ca mobilization and chemotaxis specifically in response to IP-10 and MIG, and not to other CXC or CC chemokines. IP-10 mRNA is expressed by activated T lymphocytes, neutrophils, splenocytes, keratinocytes, osteoblasts, astrocytes, endothelial cells, and smooth muscle cells . It is also expressed in inflammatory skin diseases and cutaneous T cell lymphomas. IP-10 expression has been associated with HIV infection. It can contribute to the accumulation of activated T cells in the cerebrospinal fluid compartment in HIV-1 infected individuals . The retroviral transactivator, HIV-1 Tat, is a potent inducer of IP-10 expression in astrocytes.Tat can induce expression levels of IP-10 sufficient to promote chemotaxis of peripheral blood lymphocytes. This Tat-mediated IP-10 mRNA induction can be suppressed by a mitogen-activated protein kinase (MAPK) inhibitor, thus indicating that MAPKs play a major role in Tat-mediated chemokine induction in astrocytes. IP-10 expression has also been shown to be significantly elevated in astrocytes within the brains of Alzheimer’s Disease patients .Astrocytes expressing IP-10 are commonl associated with senile plaques. The receptor for IP-10, CXCR3, can be detected constitutively on neurons and neuronal processes in various cortical and subcortical regions of the brain. |
Sample Volume | 100 μL |
Plate | Pre-coated |
Protocol | 2 This assay employs the quantitative sandwich enzyme immunoassay technique. A monoclonal antibody specific for IP-10 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any IP-10 present is bound by the immobilized antibody. An enzyme-linked polyclonal antibody specific for IP-10 is added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of IP-10 bound in the initial step. The color development is stopped and the intensity of the color is measured. |
Reagent Preparation |
Bring all reagents to room temperature before use. Wash Buffer - If crystals have formed in the concentrate, warm to room temperature and mix gently until the crystals have completely dissolved. Dilute 20 mL of Wash Buffer Concentrate into deionized or distilled water to prepare 500 mL of Wash Buffer. Standard - Reconstitute the Standard with 1.0 mL of Sample Diluent. This reconstitution produces a stock solution of 5,000 pg/mL. Allow the standard to sit for a minimum of 15 minutes with gentle agitation prior to making serial dilutions. The undiluted standard serves as the high standard (5,000 pg/mL). The Sample Diluent serves as the zero standard (0 pg/mL). Detection Reagent A and B - Dilute to the working concentration specified on the vial label using Assay Diluent A and B (1:100), respectively. |
Sample Collection | Cell culture supernates - Remove particulates by centrifugation and assay immediately or aliquot and store samples at ≤ -20 °C. Avoid repeated freeze-thaw cycles. Serum - Use a serum separator tube (SST) and allow samples to clot for 30 minutes before centrifugation for 15 minutes at approximately 1000 x g. Remove serum and assay immediately or aliquot and store samples at -20 °C. Plasma - Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge samples for 15 minutes at 1000 x g at 2 - 8 °C within 30 minutes of collection. Store samples at ≤ -20 °C. Avoid repeated freeze-thaw cycles. Saliva - Collect Saliva using a collection device such as an equivalent. assay immediately or aliquot and store samples at ≤ -20 °C. Avoid repeated freeze-thaw cycles. Note: Citrate plasma has not been validated for use in this assay. Saliva collector cannot have any enzyme binding or filtering capabilities. |
Assay Procedure |
Allow all reagents to reach room temperature. Arrange and label required number of strips. |
Calculation of Results |
Average the duplicate readings for each standard, control, and sample and subtract the average zero standard optical density. Create a standard curve by reducing the data using computer software capable of generating a four parameter logistic (4-PL) curve-fit. As an alternative, construct a standard curve by plotting the mean absorbance for each standard on the y-axis against the concentration on the x-axis and draw a best fit curve through the points on the graph. The data may be linearized by plotting the log of the IP-10 concentrations versus the log of the O.D. and the best fit line can be determined by regression analysis. This procedure will produce an adequate but less precise fit of the data. If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor. |
Restrictions | For Research Use only |
Handling Advice |
1. The kit should not be used beyond the expiration date on the kit label. 2. Do not mix or substitute reagents with those from other lots or sources. 3. If samples generate values higher than the highest standard, further dilute the samples with the Assay Diluent and repeat the assay. Any variation in standard diluent, operator, pipetting technique, washing technique,incubation time or temperature, and kit age can cause variation in binding. 4. This assay is designed to eliminate interference by soluble receptors, ligands, binding proteins, and other factors present in biological samples. Until all factors have been tested in the 3 Immunoassay, the possibility of interference cannot be excluded. |
Storage | 4 °C/-20 °C |
Storage Comment | The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20 °C upon being received. The other reagents can be stored at 4 °C. |